Xlife Sciences AG (XLS) — Net Asset Momentum
Xlife Sciences AG (XLS) recorded a net asset momentum of 13.8% as of December 2024, with net assets of CHF305.26 Million CHF. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Xlife Sciences AG liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Xlife Sciences AG Net Asset Momentum (2019–2024)
This chart tracks Xlife Sciences AG's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is +13.8%, with net assets of CHF305.26 Million CHF as of December 2024. Read XLS liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for Xlife Sciences AG (2019–2024)
The table below shows the complete annual net asset history for Xlife Sciences AG from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Xlife Sciences AG.
| Year | Net Assets (CHF) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CHF305.26 Million | CHF540.37 Million | CHF235.11 Million | ▲ +13.8% |
| 2023 | CHF268.17 Million | CHF511.99 Million | CHF243.82 Million | ▲ +14.0% |
| 2022 | CHF235.23 Million | CHF490.23 Million | CHF255.00 Million | ▲ +11.4% |
| 2021 | CHF211.23 Million | CHF480.06 Million | CHF268.83 Million | ▲ +62.3% |
| 2020 | CHF130.17 Million | CHF185.68 Million | CHF55.51 Million | ▲ +33.7% |
| 2019 | CHF97.38 Million | CHF154.02 Million | CHF56.64 Million | — |